Microsatellite analysis of serum DNA in patients with oral squamous cell carcinoma

Oncology Reports

Volumn 20, Issue 5, 2008, Pages 1195-1200

  Kakimoto, Yoshidou ^a   Yamamoto, Nobuharu ^a   Shibahara, Takahiko ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Allelic imbalances; Circulating tumor DNA; Microsatellite alteration; Oral squamous cell carcinoma; Prognosis

Indexed keywords

MICROSATELLITE DNA; PEPLEOMYCIN; DNA; TUMOR MARKER;

ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CHROMOSOME 2; CHROMOSOME 21; CHROMOSOME 3; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISTANT METASTASIS; DNA DETERMINATION; FEMALE; GENE LOCUS; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; BLOOD; BLOOD EXAMINATION; GENETICS; MIDDLE AGED; MOUTH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; HEMATOLOGIC TESTS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149337470     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000129     Document Type: Article

References (29)

1. Numasawa H, Yamamoto N, Katakura A and Shibahara T: Loss of heterozygosity and microsatellite instability on chromosome 2q in human oral squamous cell carcinoma. Bull Tokyo Dent Coll 46: 17-25, 2005.
2. Yamamoto N, Noma H and Shibahara T: Allelic imbalance on the long arm of chromosome 21 in human oral squamous cell carcinoma: relationship between allelic imbalances (LOH and MSI) and clinicopathologic features. Bull Tokyo Dent Coll 42: 211-223, 2001.
3. Arai K, Shibahara T, Yamamoto N and Noma H: The presence of candidate tumor suppressor gene loci at chromosome 3p for oral squamous cell carcinomas. Oral Oncol 38: 763-771, 2002.
4. Yamamoto N, Mizoe J, Numasawa H, Tsujii H, Shibahara T and Noma H: Allelic loss on chromosomes 2q, 3p and 21q: possibly a poor prognostic factor in oral squamous cell carcinoma. Oral Oncol 39: 796-805, 2003.
5. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
6. Ishwad CS, Ferrell RE, Rossie KM, Appel BN, Johnson JT, Myers EN, Law JC, Srivastava S and Gollin SM: Microsatellite instability in oral cancer. Int J Cancer 64: 332-335, 1995.
7. Ogawara K, Uzawa K, Nakanishi H, Yokoe H, Wang XL, Tanzawa H and Sato K: Frequent microsatellite instability in oral cancer. Oncol Rep 4: 161-165, 1997.
8. Boland CR: Setting microsatellites free. Nat Med 2: 972-974, 1996.
9. Sozzi G, Musso K, Ratcliffe C, Goldstraw P, Pierotti MA and Pastorino U: Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. Clin Cancer Res 5: 2689-2692, 1999.
10. Gonzalgo ML, Eisenberger CF, Lee SM, Trock BJ, Marshall FF, Hortopan S, Sidransky D and Schoenberg MP: Prognostic significance of preoperative molecular serum analysis in renal cancer. Clin Cancer Res 8: 1878-1881, 2002.
11. Utting M, Werner W, Dahse R, Schubert J and Junker K: Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin Cancer Res 8: 35-40, 2002.
12. Silva JM, Dominguez G, Garcia JM, Gonzales R, Villanueva MJ, Navarro F, Provencio M, San Martin S, Espana P and Bonilla F: Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res 59: 3251-3256, 1999.
13. Diep CB, Thorstensen L, Meling GI, Skovlund E, Rognum TO and Lothe RA: Genetic tumor markers with prognostic impact in Dukes' stage B and C colorectal cancer patients. J Clin Oncol 21: 820-829, 2003.
14. Nawroz H, Koch W, Anker P, Stroun M and Sidransky D: Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2: 1035-1037, 1996.
15. World Health Organization: Histological Typing of Oral and Oropharyngeal Tumours. No 4. International Histological Classification of Tumours. WHO, Geneva, 1971.
16. UICC TNM Classification of Malignant Tumors. 4th edition. Springer, Berlin, pp16-18, 1987.
17. Nakamoto D, Yamamoto N, Takagi R, Katakura A, Mizoe JE and Shibahara T: Detection of tumor DNA in plasma using whole genome amplification. Bull Tokyo Dent Coll 47: 125-131, 2006.
18. Cengiz B, Gunduz M, Nagatsuka H, Beder L, Gunduz E, Tamamura R, Mahmut N, Fukushima K, Ali Ma, Naomoto Y, Shimizu K and Nagai N: Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer. Oral Oncol 43: 241-247, 2007.
19. Hamana K, Uzawa K, Ogawara K, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma. Br J Cancer 92: 2181-2184, 2005.
20. Castells A, Puig P, Mora J, Boadas J, Boix L, Urgell E, Sole M, Capella G, Lluis F, Fernandez-Cruz L, Navarro S and Farre A: K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. J Clin Oncol 17: 578-584, 1999.
21. Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, Demeester TR, Eads C, Laird PW, Ilson DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV and Meltzer SJ: Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 92: 1805-1811, 2000.
22. Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, Pierotti MA and Tavecchio L: Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61: 4675-4678, 2001.
23. Taback B, Fujiwara Y, Wang HJ, Foshag LJ, Morton DL and Hoon DS: Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients. Cancer Res 61: 5723-5726, 2001.
24. Alikhani M, Alikhani Z, Raptis M and Graves DT: TNF-alpha in vivo stimulates opoptosis in fibroblasts through caspase-8 activation and modulates the expression of pro-apoptotic genes. J Cell Physiol 201: 341-348, 2004.
25. Han JM, Kim YS, Cho GJ, Roh GS, Kim HJ, Choi WJ, Paik WY, Rho GJ, Kang SS and Choi WS: Altered gene expression of caspase-10, death receptor-3 and IGFBP-3 in preeclamptic placentas. Mol Cell 22: 168-174, 2006.
26. Sun Y, Wang Y, Zhang J, Tao J, Wang C, Jing N, Wu C, Deng K and Qiao S: ADAM23 plays multiple roles in neuronal differentiation of P19 embryonal carcinoma cells. Neurochem Res 32: 1217-1223, 2007.
27. Chiba N and Parvin JD: The BRCA1 and BARD1 association with the RNA polymerase II holoenzyme. Cancer Res 62: 4222-4228, 2005.
28. Bökenkamp A, deJong M, van Wijk JA, Block D, van Hagen JM and Ludwig M: R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia. Pediatr Nephrol 20: 1724-1728, 2005.
29. Zhu G, Duffy DL, Turner DR, Ewen KR, Montgomery GW and Martin NG: Linkage and association analysis of radiation damage repair genes XRCC3 and XRCC5 with nevus density in adolescent twins. Twin Res 6: 315-321, 2003.